Galectin-9 Targets NLRP3 for Autophagic Degradation to Limit Inflammation.

The Journal of Immunology : Official Journal of the American Association of Immunologists
Wenwen WangWei Zhao

Abstract

NOD-, LRR-, and pyrin domain-containing protein 3 (NLRP3) inflammasome has been implicated in a variety of inflammatory disorders, and its activation should be tightly controlled to avoid detrimental effects. NLRP3 protein expression is considered as the rate-limiting step for NLRP3 inflammasome activation. In this study, we show that galectin-9 (encoded by lgals9) attenuated NLRP3 inflammasome activation by promoting the protein degradation of NLRP3 in primary peritoneal macrophages of C57BL/6J mice. Lgals9 deficiency enhances NLRP3 inflammasome activation and promotes NLRP3-dependent inflammation in C57BL/6J mice in vivo. Mechanistically, galectin-9 interacts with NLRP3, promotes the formation of NLRP3/p62 (an autophagic cargo receptor, also known as SQSTM1) complex, and thus facilitates p62-dependent autophagic degradation of NLRP3 in primary peritoneal macrophages of C57BL/6J mice and HEK293T cells. Therefore, we identify galectin-9 as an "eat-me" signal for selective autophagy of NLRP3 and uncover the potential roles of galectins in controlling host protein degradation. Furthermore, our work suggests galectin-9 as a priming therapeutic target for the diseases caused by improper NLRP3 inflammasome activation.

References

Nov 16, 2005·Nature Immunology·Chen ZhuVijay K Kuchroo
May 16, 2009·Nature Reviews. Microbiology·Gerardo R Vasta
May 20, 2009·Molecular Cell·Vladimir KirkinIvan Dikic
Jun 16, 2010·The Journal of Cell Biology·Tatsuya Saitoh, Shizuo Akira
Nov 30, 2010·Cell·Michael J Clague, Sylvie Urbé
Sep 29, 2011·Advances in Experimental Medicine and Biology·Gerardo R Vasta
Apr 30, 2013·Current Opinion in Microbiology·Keith B Boyle, Felix Randow
Jun 25, 2014·The Journal of Experimental Medicine·Shravan MadireddiMichael Croft
Nov 26, 2014·Annual Review of Pathology·Lori BroderickEicke Latz
Oct 7, 2015·Trends in Cell Biology·Aliaksandr KhaminetsIvan Dikic
May 8, 2016·Cell·Vijay A K Rathinam, Katherine A Fitzgerald
Feb 15, 2017·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Lucy Golden-Mason, Hugo R Rosen
Jul 20, 2017·Nature Immunology·Inna S AfoninaRudi Beyaert
Aug 19, 2018·Nature Communications·N GiovannoneC J Dimitroff
May 1, 2019·Nature Reviews. Immunology·Karen V SwansonJenny P-Y Ting
Sep 29, 2019·Nature Reviews. Immunology·Tao GongRongbin Zhou
Oct 11, 2019·The Journal of Immunology : Official Journal of the American Association of Immunologists·Yihui ChenGuangxun Meng
Dec 25, 2019·The Journal of Experimental Medicine·María Romina GirottiGabriel A Rabinovich
Feb 13, 2020·Journal of Cardiovascular Translational Research·Xiaohan WuChangle Liu
Mar 7, 2020·Frontiers in Immunology·Chunyuan Zhao, Wei Zhao
Jun 17, 2020·Nature Immunology·Mutian JiaWei Zhao
Nov 10, 2020·Frontiers in Immunology·Monika Biasizzo, Nataša Kopitar-Jerala

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autophagy & Model Organisms

Autophagy is a cellular process that allows degradation by the lysosome of cytoplasmic components such as proteins or organelles. Here is the latest research on autophagy & model organisms

Autophagy & Disease

Autophagy is an important cellular process for normal physiology and both elevated and decreased levels of autophagy are associated with disease. Here is the latest research.